Cytophage Technologies (TSXV:CYTO) FCF Yield % : 8.40 (As of May. 30, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Cytophage Technologies's Trailing 12-Month Free Cash Flow is C$1.94 Mil, and Market Cap is C$23.11 Mil. Therefore, Cytophage Technologies's FCF Yield % for today is 8.40%.

The historical rank and industry rank for Cytophage Technologies's FCF Yield % or its related term are showing as below:

TSXV:CYTO' s FCF Yield % Range Over the Past 10 Years
Min: -17.2 Med: 0 Max: 8.4
Current: 8.4

During the past 3 years, the highest FCF Yield % of Cytophage Technologies was 8.40%. The lowest was -17.20%. And the median was 0.00%.

TSXV:CYTO's FCF Yield % is ranked better than
97.03% of 1551 companies
in the Biotechnology industry
Industry Median: -14.39 vs TSXV:CYTO: 8.40

Cytophage Technologies's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Cytophage Technologies FCF Yield % Historical Data

The historical data trend for Cytophage Technologies's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies FCF Yield % Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

FCF Yield %

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Sep23	Dec23
FCF Yield %	-	-	-	-	-

Competitive Comparison of Cytophage Technologies's FCF Yield %

For the Biotechnology subindustry, Cytophage Technologies's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cytophage Technologies's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytophage Technologies's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Cytophage Technologies's FCF Yield % falls into.

Cytophage Technologies FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Cytophage Technologies's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.195	/	0
	=	N/A%

Cytophage Technologies's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	4	/	0
	=	N/A%

Cytophage Technologies FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Cytophage Technologies FCF Yield % Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies (TSXV:CYTO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.